Why Merck & (MRK) Stock Fell 3.6% on November 19, 2026
-3.61%$132.81November 19, 2026 · S&P 500 -1.96%
The short answer
Merck & Co. (MRK) stock is down 3.6% today, trading at $132.81. The S&P 500 ETF (SPY) is also down 2.0% in the same session, indicating that the movement is largely market-wide. Reports highlight that Merck has ended the development of Nemtabrutinib, which could be impacting investor sentiment regarding its pipeline. However, there is no single clear catalyst in the news that would directly explain the stock's decline apart from the broader market trend. The overall market decline may be influencing Merck's performance today.
The news behind it
The Zacks Analyst Blog Highlights Merck, Caterpillar, Union Pacific, Daily Journal and Community Bancorp · Zacks Investment Research · Nov 19
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know · Zacks Investment Research · Nov 19
Top Stock Reports for Merck, Caterpillar & Union Pacific · Zacks Investment Research · Nov 18
Bristol Myers vs. Merck: Which Big Pharma Stock Is the Better Buy? · Zacks Investment Research · Nov 18
Merck Ends Nemtabrutinib Development: What's Next for Its Pipeline? · Zacks Investment Research · Nov 18
Before you buy or sell
Get a second opinion on MRK
The bull case, the bear case and a verdict, with the numbers, in 10 seconds. Free →
Don't miss the next one
Alert me when MRK moves
Price, RSI and volume alerts by email or push. Free plan →
Full market recap for November 19, 2026 · What's moving MRK today
Written from that session's quote and the headlines listed above. Educational, not financial advice.